Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Get Free Report) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 2,153 shares, a decline of 54.3% from the August 15th total of 4,707 shares. Based on an average daily volume of 46,203 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are short sold.
Healthcare Capital Acquisition Trading Up 0.0%
Shares of HCAC stock traded up $0.01 on Wednesday, reaching $10.11. 15,438 shares of the company’s stock were exchanged, compared to its average volume of 89,289. The company’s fifty day simple moving average is $10.08 and its 200 day simple moving average is $10.02. Healthcare Capital Acquisition has a 52 week low of $9.91 and a 52 week high of $10.11. The stock has a market capitalization of $376.99 million, a PE ratio of 202.10 and a beta of 0.41.
Institutional Trading of Healthcare Capital Acquisition
A hedge fund recently bought a new stake in Healthcare Capital Acquisition stock. Governors Lane LP bought a new stake in shares of Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 275,000 shares of the company’s stock, valued at approximately $2,761,000. Governors Lane LP owned 0.74% of Healthcare Capital Acquisition at the end of the most recent quarter. Hedge funds and other institutional investors own 66.82% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Report on HCAC
Healthcare Capital Acquisition Company Profile
Healthcare Capital Acquisition Corp. (NASDAQ: HCAC) was a special purpose acquisition company (SPAC) formed to pursue a business combination with a company in the healthcare industry. As a blank-check company, it did not operate a healthcare business or offer its own products and services.
Its investment focus was broadly oriented toward healthcare, life sciences, medical technology, pharmaceuticals, biotechnology, diagnostics and related sectors. The company’s principal activity was identifying a suitable target, negotiating a transaction and obtaining approval from its shareholders and other stakeholders.
Because Healthcare Capital Acquisition Corp.
See Also
- Five stocks we like better than Healthcare Capital Acquisition
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Healthcare Capital Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Capital Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
